CCA
Cadent Capital Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $234K | Buy |
3,743
+3
| +0.1% | +$188 | 0.08% | 144 |
|
2025
Q1 | $225K | Buy |
3,740
+3
| +0.1% | +$181 | 0.08% | 133 |
|
2024
Q4 | $218K | Buy |
3,737
+6
| +0.2% | +$350 | 0.08% | 140 |
|
2024
Q3 | $221K | Buy |
3,731
+5
| +0.1% | +$296 | 0.07% | 146 |
|
2024
Q2 | $209K | Buy |
3,726
+4
| +0.1% | +$224 | 0.08% | 130 |
|
2024
Q1 | $218K | Buy |
3,722
+2
| +0.1% | +$117 | 0.09% | 123 |
|
2023
Q4 | $201K | Buy |
+3,720
| New | +$201K | 0.1% | 116 |
|
2023
Q3 | – | Sell |
-9,847
| Closed | -$556K | – | 131 |
|
2023
Q2 | $556K | Buy |
9,847
+10
| +0.1% | +$565 | 0.33% | 46 |
|
2023
Q1 | $531K | Buy |
9,837
+4
| +0% | +$216 | 0.24% | 52 |
|
2022
Q4 | $517K | Buy |
9,833
+13
| +0.1% | +$683 | 0.25% | 50 |
|
2022
Q3 | $463K | Buy |
9,820
+23
| +0.2% | +$1.08K | 0.26% | 54 |
|
2022
Q2 | $494K | Buy |
9,797
+9
| +0.1% | +$454 | 0.28% | 54 |
|
2022
Q1 | $597K | Buy |
9,788
+2
| +0% | +$122 | 0.27% | 60 |
|
2021
Q4 | $644K | Buy |
9,786
+12
| +0.1% | +$790 | 0.28% | 57 |
|
2021
Q3 | $614K | Buy |
9,774
+8,146
| +500% | +$512K | 0.27% | 56 |
|
2021
Q2 | $588K | Buy |
1,628
+2
| +0.1% | +$722 | 0.24% | 62 |
|
2021
Q1 | $537K | Sell |
1,626
-13,282
| -89% | -$4.39M | 0.24% | 58 |
|
2020
Q4 | $4.88M | Buy |
+14,908
| New | +$4.88M | 2.4% | 13 |
|